Stock Market Reviews

KZIA (Kazia Therapeutics Limited) News

Get the latest news, insights, and market updates on KZIA (Kazia Therapeutics Limited). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Kazia Therapeutics Announces $2.0 Million Registered Direct Offering
  Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused drug development company, today announced that it has entered into a definitive agreement for the purchase and sale of up to an aggregate of 1,333,333 of the Company's American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each ADS representing 100 ordinary shares of the Company, at a purchase price of $1.50 per ADS (or ADS equivalent in lieu thereof), in a registered direct offering. The
  Jan 10, 2025 - $KZIA